- $34.07bn
- $33.26bn
- $5.65bn
U.S. STOCKS ON THE MOVE-Intel, Colgate-Palmolive, Mohawk Industries
ResMed rises after beating quarterly profit estimates
ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices
Brief: Resmed Q1 Adjusted EPS USD 2.2 Vs. IBES Estimate USD 2.04
What to Watch in the Day Ahead - Thursday, October 24
Resmed Inc expected to post earnings of $2.04 a share - Earnings Preview
What to Watch in the Week Ahead and on Monday, October 21
U.S. RESEARCH ROUNDUP- Amerant Bancorp, BlackRock, Equinix
Brief: Resmed Unveils New Five-Year Financial Outlook
U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple
U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics
ResMed falls as Wolfe Research downgrades to 'underperform' on GLP-1 risks
KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature
Brief: Resmed Expands Board By Appointing Christopher Delorefice
Australia-listed shares of ResMed climb to 1-year high as analysts hike PT
Resmed Inc reports results for the quarter ended in January - Earnings Summary
Resmed Inc reports results for the quarter ended in June - Earnings Summary
ResMed meets estimates on steady demand for its sleep apnea devices
Brief: Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07